Precision Biotics

Brief Group Outline :

• Top R & D and a global leader in microbiome science, spin out of UCC in Cork
• Formed by a pioneering group of early innovators building on 23 years of microbiome R&D
• Founding industry partner of APC Microbiome, # 1 R&D centre for probiotics worldwide,
• Collaborating with prestigious international universities and research centres
• AH/PB is recognised for its expertise in identifying, characterising and selecting precise probiotic strains for application in medical and consumer products
• Strong patent portfolio i.e 100 patents in 10 patent families; numerous strain isolates
• Developed core strength and distinctive capability in innovative probiotic-based treatments through a “pharma like” strain identification and development process.
• Developed innovative concept of “Precision Biotics”: the best bacterial culture for each specific action supported by clinical evidence
• Flagship product: Bifidobacterium 35624 is fully focused on the treatment of cardinal symptoms of Irritable Bowel Syndrome (IBS) and is recognised as the best scientifically supported strain in IBS.
• Bifidobacterium 35624 is # 1 of all probiotics in the 3 countries where it is now established :
  • USA and Canada with > USD 240 M under brand ALIGN by P&G
  • Ireland: € 6.5 M under brand ALFLOREX for a total country population of 4.8 Million.
• Over the last 2 years, ALFLOREX has become available in > 25 countries.
• ALFLOREX has already # 1 Probiotic based IBS treatment in multiple countries such as
  • France
  • Spain
  • Mexico
  • Poland
  • Morocco…
• ALFLOREX is currently in launching phase in :
  • Germany
  • Russia
  • Turkey… 
• ALFLOREX is prescribed by HCPs (Gastros, GPs,…) and recommended in pharmacies in Europe & USA to relief IBS symptoms
• 100% Vegetal capsules compliant with Halal requirements
• Product Manufacturing in Europe according to GMP standards
• Zone IV stability studies performed
• 3-year shelf life 
• Outstanding product efficacy with repurchase rate > 60%
• New Precision Biotic franchise currently being introduced in Ireland and focusing on :
  • Coping with stress
  • Sleep and Mood Disorders
• Highly innovative proprietary and patented strain: Bifidobacterium 1714 Serenitas, acting through the brain-gut axis and marketed under the brand : ZENFLORE. 
• ZENFLORE is the first probiotic with direct evidence of a positive influence on brain activity, relating to the ability to cope with stress.
• New Product Pipeline covers a wide range of Health Areas

Preferred partnering model: Full agency distributorship